Pre-Clinical Assessment of PLK1 Inhibitors for the Treatment of Recessive Dystrophic Epidermolysis Bullosa Associated Squamous Cell Carcinoma

    Project Details

    StatusFinished
    Effective start/end date1/11/1131/10/13

    Funding

    • (South 2): £66,138.00